Psilocybin therapy for anxiety or depression in cancer survivors
Treatments studied
Part of Cancer, Mental health clinical trials.
This trial tests if a single dose of psilocybin, given with therapy, can help cancer survivors who struggle with anxiety or depression. You would travel to MD Anderson for treatment and follow-up, and must stop certain medications beforehand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had cancer (solid tumor or blood cancer) that did not spread to the brain, and you have been in remission for at least 6 months.
- You are 18 or older.
- You have a diagnosed anxiety or depression disorder that started after your cancer diagnosis.
- You are able to travel to MD Anderson Cancer Center for all appointments.
- You can stop taking antidepressants or anti-anxiety medications 2 weeks before the study.
- You have a friend or family member who can drive you home after the session.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests whether a single dose of psilocybin, a psychedelic medication, can safely and effectively treat major depression in people with cancer. If you have cancer and have been feeling depressed for at least a month, you may qualify.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.